Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Sio Gene Therapies Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 4 | 1 | −3 |
| Shares | 2.80M | 64.2K | −2.73M (−97.7%) |
| Value | $1.13M | $26.0K | −$1.11M (−97.7%) |
New holders (0)
Institutions that held Sio Gene Therapies Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (3)
Institutions that held Sio Gene Therapies Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| JBF Capital, Inc. | 2,639,127 | $1.07M |
| Cladis Investment Advisory, LLC | 80,000 | $32.3K |
| Baader Bank INC | 14,000 | $4.53K |